Skip to main content

Table 2 Clinicopathological characteristics of patients

From: Trace elements as tumor biomarkers and prognostic factors in breast cancer: a study through energy dispersive x-ray fluorescence

 

Normal tissues

Malignant tissues

Benign tissues

Age (years)

   

≤ 30

2

0

4

30–50

14

14

5

50–70

2

9

1

≥ 70

1

8

0

Menstrual status

   

Premenopausal

17

15

7

Postmenopausal

2

16

3

Tumor size (cm)

   

≤ 2

−

4

1

2–5

−

20

7

≥ 5

−

7

1

Histologic Grading

   

(Bloom and Richardson)

   

G1

−

6

−

G 2

−

12

−

G 3

−

8

−

Pathologic staging

   

I

−

0

−

II

−

10

−

III

−

9

−

IV

−

1

−

Lymph nodes

   

Negative

−

11

−

1–3

–

4

–

≥ 3

–

15

–

Death

   

Yes

0

10

0

No

19

21

9

Estrogen receptor

   

Negative

–

12

–

Positive

–

21

–

Progesterone receptor

   

Negative

–

13

–

Positive

–

20

–

HER2

   

0

–

12

–

1+

–

7

–

2+

–

8

–

3+

–

6

–